BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33039357)

  • 1. SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia.
    Condoluci A; Rossi D
    Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):779-784. PubMed ID: 33039357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of clonal evolution in chronic lymphocytic leukemia.
    Koczkodaj D; Popek-Marciniec S; Zmorzyński S; Wąsik-Szczepanek E; Filip AA
    Med Oncol; 2019 Aug; 36(9):79. PubMed ID: 31375939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study.
    Ramassone A; D'Argenio A; Veronese A; Basti A; Soliman SHA; Volinia S; Bassi C; Pagotto S; Ferracin M; Lupini L; Saccenti E; Balatti V; Pepe F; Rassenti LZ; Innocenti I; Autore F; Marzetti L; Mariani-Costantini R; Kipps TJ; Negrini M; Laurenti L; Visone R
    J Hematol Oncol; 2019 Nov; 12(1):114. PubMed ID: 31744508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts.
    Davies NJ; Kwok M; Gould C; Oldreive CE; Mao J; Parry H; Smith E; Agathanggelou A; Pratt G; Taylor AMR; Moss P; Griffiths M; Stankovic T
    Oncotarget; 2017 Jul; 8(27):44749-44760. PubMed ID: 28496009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
    Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
    Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
    Sutton LA; Rosenquist R
    Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
    Smith EN; Ghia EM; DeBoever CM; Rassenti LZ; Jepsen K; Yoon KA; Matsui H; Rozenzhak S; Alakus H; Shepard PJ; Dai Y; Khosroheidari M; Bina M; Gunderson KL; Messer K; Muthuswamy L; Hudson TJ; Harismendy O; Barrett CL; Jamieson CH; Carson DA; Kipps TJ; Frazer KA
    Blood Cancer J; 2015 Apr; 5(4):e303. PubMed ID: 25860294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
    Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
    Ojha J; Secreto C; Rabe K; Ayres-Silva J; Tschumper R; Dyke DV; Slager S; Fonseca R; Shanafelt T; Kay N; Braggio E
    Leukemia; 2014 Dec; 28(12):2395-8. PubMed ID: 25034147
    [No Abstract]   [Full Text] [Related]  

  • 10. Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.
    Zaborsky N; Gassner FJ; Höpner JP; Schubert M; Hebenstreit D; Stark R; Asslaber D; Steiner M; Geisberger R; Greil R; Egle A
    Leukemia; 2019 Apr; 33(4):957-968. PubMed ID: 30262843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.
    Zapatka M; Tausch E; Öztürk S; Yosifov DY; Seiffert M; Zenz T; Schneider C; Blöhdorn J; Döhner H; Mertens D; Lichter P; Stilgenbauer S
    Haematologica; 2022 Mar; 107(3):604-614. PubMed ID: 33691380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring.
    Derrieux C; Gish A; Caulier A; Grardel N; Garidi R; Joris M; Assouan D; Poulain S; Decool G; Ferret Y; Caillault-Venet A; Marolleau JP; Preudhomme C; Boyer T
    Br J Haematol; 2020 Nov; 191(3):506-509. PubMed ID: 32754904
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia.
    Wang J; Khiabanian H; Rossi D; Fabbri G; Gattei V; Forconi F; Laurenti L; Marasca R; Del Poeta G; Foà R; Pasqualucci L; Gaidano G; Rabadan R
    Elife; 2014 Dec; 3():. PubMed ID: 25496728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance.
    Condoluci A; Rossi D
    J Natl Compr Canc Netw; 2020 Dec; 19(2):227-233. PubMed ID: 33383567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive analysis of genetic aberrations and cell of origin in Richter transformation.
    Chitalia A; Swoboda DM; McCutcheon JN; Ozdemirli M; Khan N; Cheson BD
    Leuk Lymphoma; 2019 Apr; 60(4):971-979. PubMed ID: 30632835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
    Playa-Albinyana H; Arenas F; Royo R; Giró A; López-Oreja I; Aymerich M; López-Guerra M; Frigola G; Beà S; Delgado J; Garcia-Roves PM; Campo E; Nadeu F; Colomer D
    Leukemia; 2024 Mar; 38(3):557-569. PubMed ID: 38017105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
    Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
    J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
    Leeksma AC; Taylor J; Wu B; Gardner JR; He J; Nahas M; Gonen M; Alemayehu WG; Te Raa D; Walther T; Hüllein J; Dietrich S; Claus R; de Boer F; de Heer K; Dubois J; Dampmann M; Dürig J; van Oers MHJ; Geisler CH; Eldering E; Levine RL; Miller V; Mughal T; Lamanna N; Frattini MG; Heaney ML; Zelenetz A; Zenz T; Abdel-Wahab O; Kater AP
    Leukemia; 2019 Feb; 33(2):390-402. PubMed ID: 30038380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic evolution in chronic lymphocytic leukaemia.
    Delgado J; Villamor N; López-Guillermo A; Campo E
    Best Pract Res Clin Haematol; 2016 Mar; 29(1):67-78. PubMed ID: 27742073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.